NCT06174831

Study of a Series of Patients Treated for Retrograde Cricopharyngeal Muscle Dysfunction Syndrome

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: University Hospital, Strasbourg, France · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

R-CPD syndrome (Retrograde Cricopharyngeal Dysfunction syndrome) is an inability to burp. It is a syndrome whose diagnosis is clinical, and for which there is effective treatment. Recently treated in the United States (first publication in 2019), this syndrome affects many patients in France and is currently unknown. This study concerns a series of patients treated at the University Hospitals of Strasbourg for a syndrome of retrograde dysfunction of the cricopharyngeus muscle having been treated by injection of botulinum toxin into the cricopharyngeus muscle.

Conditions

• Deglutition Disorders

Timeline

• Start date: 2023-02-01
• Primary completion: 2024-01-01
• Completion: 2024-01-19
• First posted: 2023-12-18
• Last updated: 2023-12-18

Locations

1 site across 1 country: France